Cryopreserved Immune Cells to the Rescue!

  When the Covid-19 pandemic upended daily lives, biomedical research across the globe felt the strain as pandemic-related shipping and manufacturing delays began leading to supply line shortages. As lockdowns were instituted, cell therapy starting material became particularly difficult to source because the COVID-19 pandemic posed risks to donors traveling to hospitals and clinics. With…